Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

BC3448

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Wuxi Biocity

Drug class:

EGFR inhibitor, CD3 agonist

Related drugs:

‹

UMG2-CD3 BTCE (0)

Undisclosed HER2Bi-armed ATC (0)

cetuximab (347)

osimertinib (301)

erlotinib (235)

gefitinib (194)

panitumumab (123)

lapatinib (107)

neratinib (102)

brigatinib (50)

amivantamab-vmjw (25)

firmonertinib (14)

mobocertinib (12)

lazertinib (12)

tarloxotinib bromide (7)

nimotuzumab (6)

rociletinib (5)

tomuzotuximab (4)

necitumumab (3)

befotertinib (3)

sunvozertinib (3)

zorifertinib (3)

ABP 494 (cetuximab biosimilar) (1)

Compound 6a (1)

abivertinib (1)

sevabertinib (1)

cetuximab biosimilar (0)

STI-001 (cetuximab biosimilar) (0)

antroquinonol (0)

zalutumumab (0)

JNJ-26483327 (0)

asandeutertinib (0)

PF-06747775 (0)

JNJ-64041757 (0)

PF-08046052 (0)

rindopepimut (0)

amivantamab and hyaluronidase-lpuj (0)

Undisclosed EGFR inhibitor (0)

blinatumomab (53)

epcoritamab-bysp (11)

elranatamab-bcmm (8)

tebentafusp-tebn (7)

tarlatamab-dlle (4)

mosunetuzumab-axgb (2)

talquetamab-tgvs (2)

teclistamab-cqyv (2)

glofitamab-gxbm (1)

odronextamab (1)

JNJ-63898081 (1)

activated CIK and bispecific antibody (0)

activated CIK-anti-CD3/MUC1/CEA/EpCAM/GPC3 antibody (0)

CD30 biAb-AATC (0)

ABBV-383 IV (0)

huCD33-BsAb (0)

JNJ-63709178 (0)

JNJ-67571244 (0)

catumaxomab (0)

linvoseltamab-gcpt (0)

PF-06671008 (0)

PF-07062119 (0)

PF-07260437 (0)

UMG2-CD3 BTCE (0)

Undisclosed HER2Bi-armed ATC (0)

›